Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Return on Assets (2021 - 2025)

Historic Return on Assets for Vivos Therapeutics (VVOS) over the last 5 years, with Q3 2025 value amounting to 0.66%.

  • Vivos Therapeutics' Return on Assets rose 1400.0% to 0.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.66%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.86% for FY2024, which is 2500.0% up from last year.
  • Latest data reveals that Vivos Therapeutics reported Return on Assets of 0.66% as of Q3 2025, which was up 1400.0% from 0.77% recorded in Q2 2025.
  • Vivos Therapeutics' 5-year Return on Assets high stood at 0.44% for Q3 2021, and its period low was 1.48% during Q4 2022.
  • For the 5-year period, Vivos Therapeutics' Return on Assets averaged around 0.92%, with its median value being 0.85% (2025).
  • Per our database at Business Quant, Vivos Therapeutics' Return on Assets tumbled by -9400bps in 2022 and then skyrocketed by 5600bps in 2024.
  • Quarter analysis of 5 years shows Vivos Therapeutics' Return on Assets stood at 0.54% in 2021, then tumbled by -173bps to 1.48% in 2022, then rose by 13bps to 1.29% in 2023, then surged by 44bps to 0.73% in 2024, then rose by 9bps to 0.66% in 2025.
  • Its Return on Assets stands at 0.66% for Q3 2025, versus 0.77% for Q2 2025 and 0.85% for Q1 2025.